A Trial Investigating the Pharmacodynamic and Pharmacokinetic Properties of Insulin Degludec/Insulin Aspart 15 in Subjects With Type 1 Diabetes

NCT01773798 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

33

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1

Interventions

DRUG: insulin degludec/insulin aspart 15
DRUG: insulin degludec/insulin aspart
DRUG: insulin degludec
DRUG: insulin aspart
DRUG: placebo

Sponsor

Novo Nordisk A/S